Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD
This study has been terminated.
Study NCT00032773   Information provided by SuperGen
First Received: April 2, 2002   Last Updated: October 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Graft Versus Host Disease
Additional conditions recognized in this trial
Graft vs Host Disease
More general conditions related to this trial
Immune System Diseases
Interventions listed in this trial
pentostatin for injection
Additional drug interventions recognized in this trial
Pentostatin
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
SuperGen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services